Mariah Lelos

Dr. Mariah Lelos


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Cell Stem Cell
Verified
Journal Article
Open access
AKAgnete Kirkeby
Agnete Kirkeby
SNSara Nolbrant
Sara Nolbrant
KTKatarina Tiklova
Katarina Tiklova
AHAndreas Heuer
Andreas Heuer
NKNigel Kee
Nigel Kee
MPMalin Parmar
Malin Parmar
Stem cell treatments for neurodegenerative diseases are expected to reach clinical trials soon. Most of the approaches currently under development involve transplantation of immature progenitors that subsequently undergo phenotypic and functional maturation in vivo, and predicting the long-term graft outcome already at the progenitor stage remains a challenge. Here, we took an unbiased approach to identify predictive markers expressed in dopamine neuron progenitors that correlate with graft outcome in an animal model of Parkinson's disease through gene expression analysis of >30 batches of grafted human embryonic stem cell (hESC)-derived progenitors. We found that many of the commonly used markers did not accurately predict in vivo subtype-specific maturation. Instead, we identified a specific set of markers associated with the caudal midbrain that correlate with high dopaminergic yield after transplantation in vivo. Using these markers, we developed a good manufacturing practice (GMP) differentiation protocol for highly efficient and reproducible production of transplantable dopamine progenitors from hESCs.

15 January 2013 in Development
Verified
Journal Article
Open access
PDF file
ACAlessia Delli Carri
Alessia Delli Carri
MOMarco Onorati
Marco Onorati
MLMariah Lelos
Mariah Lelos
VCValentina Castiglioni
Valentina Castiglioni
AFAndrea Faedo
Andrea Faedo
ECElena Cattaneo
Elena Cattaneo
Medium-sized spiny neurons (MSNs) are the only neostriatum projection neurons, and their degeneration underlies some of the clinical features of Huntington’s disease. Using knowledge of human developmental biology and exposure to key neurodevelopmental molecules, human pluripotent stem (hPS) cells were induced to differentiate into MSNs. In a feeder-free adherent culture, ventral telencephalic specification is induced by BMP/TGFβ inhibition and subsequent SHH/DKK1 treatment. The emerging FOXG1+/GSX2+ telencephalic progenitors are then terminally differentiated, resulting in the systematic line-independent generation of FOXP1+/FOXP2+/CTIP2+/calbindin+/DARPP-32+ MSNs. Similar to mature MSNs, these neurons carry dopamine and A2a receptors, elicit a typical firing pattern and show inhibitory postsynaptic currents, as well as dopamine neuromodulation and synaptic integration ability in vivo. When transplanted into the striatum of quinolinic acid-lesioned rats, hPS-derived neurons survive and differentiate into DARPP-32+ neurons, leading to a restoration of apomorphine-induced rotation behavior. In summary, hPS cells can be efficiently driven to acquire a functional striatal fate using an ontogeny-recapitulating stepwise method that represents a platform for in vitro human developmental neurobiology studies and drug screening approaches.


28 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
JSJeroen B. I. Sap
Jeroen B. I. Sap
CMClaudio F. Meyer
Claudio F. Meyer
JFJoseph Ford
Joseph Ford
NSNatan Straathof
Natan Straathof
ADAlexander B. Dürr
Alexander B. Dürr
VGVéronique Gouverneur
Véronique Gouverneur


1 December 2011 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RTRhian S. Thomas
Rhian S. Thomas
MLMariah Lelos
Mariah Lelos
MGMark A. Good
Mark A. Good
EKEmma J. Kidd
Emma J. Kidd